Calypte Enters Into Memorandum of Understanding with Beijing Tiantan Biological Products Construction on Chinese Manufacturing Facility Underway...
Calypte Finalizes Manufacturing Agreement for Rapid Tests Technology Transfer Scheduled for June ALAMEDA, Calif., May 11 /PRNewswire-FirstCall/...
Calypte Announces Execution of a Research and Development Agreement With CDC for Rapid HIV Incidence Test ALAMEDA, Calif., April 14...
Calypte Announces License From CDC for HIV Incidence Test ALAMEDA, Calif., April 12 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation...
Calypte Appoints New Board Member Maxim A. Soulimov, Director of Legal Affairs of Global Corporate Ventures Limited, Appointed to the Company's...
Calypte Launches International Manufacturing Initiative of its Rapid HIV Type 1 and HIV Type 2 Tests Announces License and Supply Agreement with...
Calypte Announces Fourth Quarter and Year End Results Marr Technologies B.V. Increases Loan Commitment to $15 Million ALAMEDA, Calif., March 23...
Calypte Biomedical and Earvin 'Magic' Johnson Commemorate World AIDS Day December 1st ALAMEDA, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Calypte...
Calypte Biomedical Announces Third Quarter and Nine-Month Financial Results ALAMEDA, Calif., Nov. 14 /PRNewswire-FirstCall/ -- Calypte...
Calypte Biomedical to Host 3rd Quarter Financial Results Conference Call On November 17 ALAMEDA, Calif., Nov. 14 /PRNewswire-FirstCall/...
Calypte Biomedical Submits Investigational Device Exemption Application for HIV-1 Rapid Blood Test ALAMEDA, Calif., Nov. 6...
Calypte Biomedical to File Form 8K ALAMEDA, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (BULLETIN BOARD: CYPT...
Marr Technologies Clarifies Ownership Position in Calypte Biomedical Member of the Marr Group Acquired a Total of 5.4 Million Shares Through...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.